Sunhawk Vision Biotech, Inc. (TPEX:7759)

Sunhawk Vision Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-162.51	-87.85	-25.1
Depreciation & Amortization	5.06	4.71	1.32
Other Amortization	0.04	0.04	0.06
Loss (Gain) From Sale of Assets	0.74	0.68	-
Other Operating Activities	-0.56	0.21	-72.87
Change in Accounts Payable	15.76	-4.54	-43.82
Change in Other Net Operating Assets	-1.94	-8.25	65.29
Operating Cash Flow	-143.4	-95.01	-75.11
Capital Expenditures	-0.62	-1.06	-3.13
Sale (Purchase) of Intangibles	-	-	-0.19
Investment in Securities	-130	-37.9	-12.54
Other Investing Activities	0	-0.69	-0.33
Investing Cash Flow	-130.62	-39.64	-16.19
Long-Term Debt Repaid	-	-2.86	-0.57
Net Debt Issued (Repaid)	-3.72	-2.86	-0.57
Issuance of Common Stock	421.8	74	219.39
Financing Cash Flow	418.08	71.14	218.81
Foreign Exchange Rate Adjustments	-1.61	-0.17	0.75
Net Cash Flow	142.46	-63.67	128.26
Free Cash Flow	-144.02	-96.06	-78.24
Free Cash Flow Per Share	-2.17	-1.54	-1.27
Cash Interest Paid	0.2	0.19	0.02
Cash Income Tax Paid	0.67	0.51	0.06
Levered Free Cash Flow	-82.56	-72.86	-
Unlevered Free Cash Flow	-82.43	-72.74	-
Change in Working Capital	13.83	-12.78	21.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.